Cardiovascular Outcomes During Index Hospitalization in Children with Kawasaki Disease in Ontario, Canada

[1]  H. Seow,et al.  Health care utilization and costs following Kawasaki disease. , 2022, Paediatrics & child health.

[2]  R. Chanchlani,et al.  Long-term hearing and neurodevelopmental outcomes following Kawasaki disease: A population-based cohort study , 2021, Brain and Development.

[3]  E. Benchimol,et al.  Incidence and short-term outcomes of Kawasaki disease , 2021, Pediatric Research.

[4]  Yosikazu Nakamura,et al.  Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki Disease: The Nationwide Survey in Japan, 2017-2018. , 2020, The Journal of pediatrics.

[5]  K. Waki,et al.  Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events , 2018, JAMA pediatrics.

[6]  Y. Hua,et al.  Ventricular arrhythmia as an initial sign in acute Kawasaki disease , 2018, Medicine.

[7]  B. McCrindle,et al.  Epidemiology of Kawasaki Disease in Canada 2004 to 2014: Comparison of Surveillance Using Administrative Data vs Periodic Medical Record Review. , 2017, The Canadian journal of cardiology.

[8]  N. Dahdah,et al.  Myocarditis and Kawasaki disease , 2017, International journal of rheumatic diseases.

[9]  B. McCrindle,et al.  Factors associated with development of coronary artery aneurysms after Kawasaki disease are similar for those treated promptly and those with delayed or no treatment. , 2017, International journal of cardiology.

[10]  B. McCrindle,et al.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association , 2017, Circulation.

[11]  J. Newburger,et al.  Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population , 2016, Journal of the American Heart Association.

[12]  David Moher,et al.  The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) Statement: Methods for Arriving at Consensus and Developing Reporting Guidelines , 2015, PloS one.

[13]  D. Burgner,et al.  The epidemiology of Kawasaki disease: a global update , 2015, Archives of Disease in Childhood.

[14]  E. Wu,et al.  Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous γ-immunoglobulin therapy , 2015, Archives of Disease in Childhood.

[15]  A. Marks,et al.  Long-term Cardiovascular Outcomes in Survivors of Kawasaki Disease , 2014, Pediatrics.

[16]  B. McCrindle,et al.  Long-term management of Kawasaki disease: implications for the adult patient. , 2013, Pediatrics and neonatology.

[17]  Dionne A. Graham,et al.  Diastolic function in children with Kawasaki disease. , 2011, International journal of cardiology.

[18]  S. Colan,et al.  Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease. , 2011, Journal of the American College of Cardiology.

[19]  J. Stockman.  Treatment of Kawasaki Disease: Analysis of 27 US Pediatric Hospitals From 2001 to 2006 , 2011 .

[20]  H. Sugiyama,et al.  The 30-Year Outcome for Patients After Myocardial Infarction Due to Coronary Artery Lesions Caused By Kawasaki Disease , 2011, Pediatric Cardiology.

[21]  J. Tu,et al.  Surname lists to identify South Asian and Chinese ethnicity from secondary data in Ontario, Canada: a validation study , 2010, BMC medical research methodology.

[22]  Y. T. Lin,et al.  Repeated systematic surveillance of Kawasaki disease in Ontario from 1995 to 2006 , 2010, Pediatrics international : official journal of the Japan Pediatric Society.

[23]  B. McCrindle,et al.  Comparison of factors associated with coronary artery dilation only versus coronary artery aneurysms in patients with Kawasaki disease. , 2009, The American journal of cardiology.

[24]  Andrew M Kahn,et al.  When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood. , 2009, Journal of the American College of Cardiology.

[25]  K. Gauvreau,et al.  Treatment of Kawasaki Disease: Analysis of 27 US Pediatric Hospitals From 2001 to 2006 , 2009, Pediatrics.

[26]  J. Kanegaye,et al.  Recognition of a Kawasaki Disease Shock Syndrome , 2009, Pediatrics.

[27]  JungHwa Lee,et al.  Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age , 2009, European Journal of Pediatrics.

[28]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2008, Journal of clinical epidemiology.

[29]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[30]  Toshio Shimizu,et al.  Changes in causes of sudden deaths by decade in patients with coronary arterial lesions due to Kawasaki disease , 2005, Cardiology in the Young.

[31]  T. Kamiya,et al.  Cardiac biopsy in Kawasaki disease , 1981, Heart and Vessels.

[32]  J. Furui,et al.  Older Age Is a Risk Factor for the Development of Cardiovascular Sequelae in Kawasaki Disease , 2004, Pediatrics.

[33]  R. Holman,et al.  Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. , 2003, Pediatrics.

[34]  Kozo Matsumoto,et al.  Long-term consequences of Kawasaki disease among first-year junior high school students. , 2002, Archives of pediatrics & adolescent medicine.

[35]  S. Colan,et al.  Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin. , 2000, American heart journal.

[36]  K. Taubert.  Epidemiology of Kawasaki disease in the United States and worldwide , 1997 .

[37]  K Hashino,et al.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. , 1996, Circulation.

[38]  T. Nakada,et al.  Histopathological study on Kawasaki disease with special reference to the relation between the myocardial sequelae and regional wall motion abnormalities of the left ventricle. , 1992, Japanese circulation journal.

[39]  S. Kaplan,et al.  Long-term echocardiographic evaluation of cardiac size and function in patients with Kawasaki disease. , 1985, American heart journal.

[40]  T. Kozuka,et al.  Histopathological study on right endomyocardial biopsy of Kawasaki disease. , 1980, British heart journal.